PTC Therapeutics Inc. buy Wells Fargo & Company
Start price
08.12.23
/
50%
€24.20
Target price
08.12.24
€34.41
Performance (%)
28.93%
Price
20.05.24
€31.20
Summary
This prediction is currently active. The prediction currently has a performance of 28.93%. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 6.849% | 6.849% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Wells_Fargo___Compan for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $37.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat